Monopar Therapeutics Reports Second Quarter 2021 Financial Results and Recent Business Updates

NEXT STORY
Junshi Biosciences and Coherus Announce U.S. FDA Breakthrough Therapy Designation Granted for Toripalimab for 1st Line Treatment of Nasopharyngeal Carcinoma
PREV STORY
Rhythm Pharmaceuticals to Present at the 59th Annual ESPE Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

$2.4 Bn Veterinary Equipment and Disposables Market by Product, Animal, End User – Global Forecast to 2023

Dublin, Sept. 14, 2018 (GLOBE NEWSWIRE) -- The "Veterinary Equipment and Disposables Market by ...

author_avatar
NASDAQ Market News

VBL Therapeutics Presents Late Breaking Research Demonstrating Immune-cell Mediated Killing of Cancer Cells by a Novel Bi-specific Antibody at AACR

author_avatar
NASDAQ Market News

Roche announces FDA approval of Gavreto (pralsetinib) for the treatment of adults with metastatic RET fusion-positive non-small cell lung cancer

author_avatar
NASDAQ Market News